Recent Updates
Recently added Catalysts
BWAY Positive Sentiment

Accelerated deep transcranial magnetic stimulation using iTBS protocol for refractory obsessive-compulsive disorder

Key Takeaway: The article discusses two cases showcasing the safety and potential effectiveness of an accelerated deep transcranial magnetic stimulation (dTMS) protocol for treating refractory obsessive-compulsive disorder (OCD). This new approach may offer quicker clinical improvements compared to conventional methods. However, the need for additional sessions to ensure sustained responses remains uncertain, highlighting the necessity for more systematic studies.
Price reaction · baseline $2.49 (2023-11-21 close) · hit pre-market · 4 other BWAY headline(s) in the window, move may be shared
day 0 close
+10.6%
day 1
+17.1%
day 3 · peak
+23.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Demonstrated potential clinical effectiveness in treating OCD.
  • Accelerated protocol may lead to quicker clinical improvement.
  • Intermittent theta-burst stimulation (iTBS) is more tolerable.

CONCERNS & RISKS

  • One patient relapsed within a few weeks.
  • Insufficient follow-up data for one patient.
  • Need for further investigation to determine long-term efficacy.

Full Press Release Details

Summary:

Two patient cases illustrate the safety and potential clinical effectiveness of an accelerated deep transcranial magnetic stimulation (dTMS) protocol as an adjunctive approach in treating OCD. In contrast to the conventional once-daily protocol, the accelerated protocol may lead to quicker clinical improvement. However, it remains to be determined whether a higher number of sessions is necessary for a sustained response.
The FDA-approved high-frequency (HF) dTMS protocol for OCD involves 50 trains of 2 seconds at 20Hz, with a 20-second inter-train interval, totaling 2000 pulses per session and taking 18 minutes. We utilized an intermittent theta-burst stimulation (iTBS) protocol with 1200 pulses per session, delivered in only 6 minutes, potentially making it more tolerable.
While the improvement observed was modest, the rapid changes in treatment-refractory patients were encouraging. Nevertheless, one patient relapsed within a few weeks, and the other lacked sufficient follow-up data. Further investigation is needed to assess whether protocol optimization or maintenance sessions are required for sustaining improvement.
In summary, the experiences with these two cases underscore the necessity for more systematic studies to evaluate the efficacy and tolerability of accelerated dTMS in OCD
Full Article:

Frequently Asked Questions

What is accelerated dTMS?

Accelerated dTMS is a deep transcranial magnetic stimulation protocol that aims to provide quicker clinical improvements in treating conditions like OCD.

How does the iTBS protocol differ from conventional dTMS?

The iTBS protocol delivers 1200 pulses in 6 minutes, compared to the conventional method that takes 18 minutes for 2000 pulses.

What were the outcomes of the patient cases discussed?

One patient showed modest improvement but relapsed, while the other had insufficient follow-up data.

Is further research needed for accelerated dTMS?

Yes, more systematic studies are required to evaluate the efficacy and tolerability of accelerated dTMS in OCD.

Last updated: Nov 22, 2023